Compare GKOS & QBTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GKOS | QBTS |
|---|---|---|
| Founded | 1998 | 1999 |
| Country | United States | United States |
| Employees | N/A | 388 |
| Industry | Medical/Dental Instruments | Retail: Computer Software & Peripheral Equipment |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.0B | 7.1B |
| IPO Year | 2015 | N/A |
| Metric | GKOS | QBTS |
|---|---|---|
| Price | $122.45 | $28.34 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 12 | 15 |
| Target Price | ★ $126.92 | $32.53 |
| AVG Volume (30 Days) | 779.2K | ★ 24.8M |
| Earning Date | 04-29-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $507,442,000.00 | N/A |
| Revenue This Year | $23.32 | $81.05 |
| Revenue Next Year | $27.43 | $93.13 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 32.33 | N/A |
| 52 Week Low | $73.16 | $12.75 |
| 52 Week High | $148.11 | $46.75 |
| Indicator | GKOS | QBTS |
|---|---|---|
| Relative Strength Index (RSI) | 40.86 | 68.53 |
| Support Level | $79.59 | $26.37 |
| Resistance Level | $123.09 | $30.77 |
| Average True Range (ATR) | 6.56 | 2.23 |
| MACD | -1.43 | 0.33 |
| Stochastic Oscillator | 5.60 | 77.63 |
Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases. It has commenced commercialization activities for iDose TR, a first-of-its-kind, long-duration, intracameral procedural pharmaceutical implant designed to continuously deliver glaucoma drug therapy inside the eye for extended periods of time. The company also offer commercially a proprietary bio-activated pharmaceutical therapy for the treatment of a rare corneal disorder, keratoconus. The company has three primary commercialized micro-scale surgical device products designed to treat glaucoma: the iStent, the iStent inject W, and the iStent infinite.
D-Wave Quantum Inc is in the development and delivery of quantum computing systems, software, and services, and it is the commercial supplier of quantum computers and the only company building both annealing quantum computers and gate-model quantum computers. It delivers customer value with practical quantum applications for problems as diverse as logistics, artificial intelligence, materials sciences, drug discovery, scheduling, cybersecurity, fault detection, and financial modeling. Its annealing quantum computers are accessible through the company's LeapTM cloud service.